NHS National Generic Pharmaceuticals Wave 15a
Details
- Buyer
- NHS England
- Supplier(s)
114 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- Accord UK Ltd
- AFT Pharma UK
- AGB Pharma
- Aguettant Ltd
- Alturix
- Amarox Ltd
- AOP Orphan Ltd
- Arcadia Pharma Limited T/A Arcadia Medical
- Aristo Pharma Ltd
- Ascend Laboratories (UK) Limited
- Aspen Pharmacare UK Limited
- Aspire Pharma Ltd
- B. BRAUN MEDICAL LIMITED
- Bausch + Lomb (Pharma)
- Baxter Healthcare Ltd
- Beaumont Pharma Ltd
- Biocon
- Bowmed Ibisqus Ltd
- Brown and Burk
- Celix Pharma Ltd.
- Chiesi Ltd
- Cipla
- Colonis Pharma Limited
- Consilient Health Ltd
- Correvio GmbH
- Crescent Pharma Limited
- CST Pharma Limited
- Day Lewis Medical Ltd
- Desitin Pharma Ltd
- Dr Reddy's Laboratories (UK) Ltd
- DRUGSRUS LIMITED
- Ennogen HealthCare
- Eramol (UK) Ltd
- Esteve Pharmaceuticals Ltd
- Evolan Pharma
- Farmak Pharmaceuticals
- Ferring Pharmaceutical
- Flexipharm Austrading Ltd
- FLYNN PHARMA LTD
- Focus Pharmaceuticals Ltd
- Fontus Health Ltd
- FRESENIUS KABI LIMITED
- Galvany Pharma Ltd
- GENNISIUM PHARMA
- GL Pharma UK Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Grindeks Kalceks UK Ltd
- Grunenthal Ltd
- Hameln Pharma Ltd
- Hikma Pharmaceuticals
- Immedica Pharma AB
- Kent Pharma Ltd
- Lipomed AG
- LogixX Pharma Ltd
- Lucane Pharma
- Lundbeck Limited
- Macleods Pharma UK Limited
- Macure Pharma ApS
- Manx Healthcare Ltd
- Martindale Pharma
- medac Pharma LLP
- Medreich Plc
- MERCK SHARP & DOHME (UK) LIMITED
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- MMEU Limited
- Morningside Pharmaceuticals Ltd
- MSN Laboratories Europe Limited
- Necessity Supplies Ltd
- Neuraxpharm UK Ltd
- Novartis Pharmaceutical UK Ltd
- Novumgen Limited
- Orion Pharma (UK) Ltd
- Otsuka Pharmaceuticals UK Limited
- Panpharma UK Ltd
- Pari Medical UK
- Perennial Pharma Ltd
- Pfizer Liimted
- Phoenix Lab
- Pierre Fabre Ltd
- Piramal Critical Care Ltd
- Ranbaxy (UK) Ltd
- Recordati Pharmaceuticals Ltd
- Reig Jofre UK Ltd
- Rivopharm
- Roma Pharmaceuticals Limited
- Rosemont Pharmaceuticals Ltd
- ROVI BIOTECH LIMITED
- RPH Pharmaceuticals AB
- Sandoz
- Scope Ophthalmics Ltd
- Seacross Pharmaceuticals Ltd
- Selective Supplies Ltd
- Stirling Anglian Pharmaceuticals Ltd
- Strides Pharma Uk LTD
- SVP Pharma Ltd
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Synchrony
- Takeda UK Limited
- Tetris Pharma Lts
- Teva UK Ltd
- Thea Pharmaceuticals Ltd
- Thornton and Ross
- Tillomed Laboratories Ltd
- Torbay Pharmaceuticals
- Torrent Pharma (UK) Ltd
- Vantage Pharmaceuticals Ltd
- Viatris UK Healthcare Ltd
- Waymade plc
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- £170
- Topic
- Pharmaceutical products
- Published
- 18 December 2024
- Source
- uk:find_a_tender
Tender description
NHS National Generic Pharmaceuticals - Wave 15a.<br/>Offer reference number: CM/PHG/23/5697.<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/23/5697/01 – Orals (plus non-parenteral) Products:<br/>All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months)<br/><br/>CM/PHG/23/5697/02 – Hospital Only Products:<br/>DNW & DLN: 01/02/2025 to 31/01/2027 (24 months)<br/><br/>CM/PHG/23/5697/03 – Hospital Only Products (Housekeeping):<br/>DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)<br/>DCE & DSW: 01/02/2025 to 30/09/2025 (8 months) Lot 1: Lot 1 - CM/PHG/23/5697/01 Orals (plus non-parenteral) Products Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/23/5697/01 – Orals (plus non-parenteral) Products:<br/>All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. Lot 2: Lot 2 - CM/PHG/23/5697/02 Hospital Only Products Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/23/5697/02 – Hospital Only Products:<br/>DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. Lot 3: Lot 3 - CM/PHG/23/5697/03 Hospital Only Products (Housekeeping) Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/23/5697/03 – Hospital Only Products (Housekeeping):<br/>DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)<br/>DCE & DSW: 01/02/2025 to 30/09/2025 (8 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
Timeline
- Completed: Award date5 November 2024
- Completed: Award published18 December 2024Current notice
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Generic Drugs - Oral Liquids
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 510£244.6m
- 449£1.6bn
- 408£111.7m
- 400£699.7m
- 326£1.2bn
- 321£24.3bn
- 291£1.6bn
- 255£3.1bn
- 156£125.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.